Clinical Trial Update: Study to Evaluate Efficacy of PDR001 in Patients With Squamous Cell Carcinoma of the Esophagus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PDR001 in patients with unresectable or metastatic esophageal squamous cell carcinoma who failed standard treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• PDR001

Snippet

Sponsor: Yonsei University | Conditions: Histologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard Treatment | Phase 2 | Status: UNKNOWN